Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
22
ADN Quote, Financials, Valuation and Earnings
Last price:
$1.95
Seasonality move
:
-15.83%
Day range:
$1.85 - $1.99
52-week range:
$1.71 - $8.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.25x
P/B ratio:
1.66x
Volume:
163.8K
Avg. volume:
36K
1-year change:
-48.95%
Market cap:
$5.2M
Revenue:
$3.3M
EPS (TTM):
-$27.40
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $882.7K | $7.1M | $7.8M | $1.5M | $3.3M | |
| Revenue Growth (YoY) | -- | 700.88% | 10.86% | -80.4% | 113.28% | |
| Cost of Revenues | $513.8K | $5.4M | $8.6M | $7M | $1.5M | |
| Gross Profit | $368.8K | $1.7M | -$744K | -$5.4M | $1.8M | |
| Gross Profit Margin | 41.79% | 23.53% | -9.49% | -353.39% | 54.58% | |
| R&D Expenses | $102.5K | $3.5M | $9.8M | $7.6M | $3.2M | |
| Selling, General & Admin | $3.5M | $41.9M | $35.9M | $28.8M | $14.3M | |
| Other Inc / (Exp) | -$41.8K | $22.7M | -$29.9M | -$9.6M | -$11M | |
| Operating Expenses | $3.4M | $45.8M | $45.8M | $36.1M | $20.3M | |
| Operating Income | -$3.1M | -$44.1M | -$46.5M | -$41.5M | -$18.5M | |
| Net Interest Expenses | $5.5K | $51K | -- | -- | $535K | |
| EBT. Incl. Unusual Items | -$3.1M | -$21.4M | -$76.3M | -$51M | -$30.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$20.5M | -$11M | |
| Income Tax Expense | -- | -$923K | -$2M | -$82K | -$55K | |
| Net Income to Company | -$3.1M | -$20.5M | -$74.3M | -$50.9M | -$30M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.1M | -$20.5M | -$74.3M | -$71.4M | -$41M | |
| Basic EPS (Cont. Ops) | -$4.50 | -$13.50 | -$43.28 | -$37.24 | -$15.65 | |
| Diluted EPS (Cont. Ops) | -$4.50 | -$13.50 | -$43.28 | -$37.24 | -$15.65 | |
| Weighted Average Basic Share | $684K | $1.5M | $1.7M | $1.9M | $2.6M | |
| Weighted Average Diluted Share | $684K | $1.5M | $1.7M | $1.9M | $2.6M | |
| EBITDA | -$3.1M | -$42.4M | -$42.2M | -$39M | -$16.9M | |
| EBIT | -$3.1M | -$44.1M | -$46.5M | -$41.5M | -$18.5M | |
| Revenue (Reported) | $882.7K | $7.1M | $7.8M | $1.5M | $3.3M | |
| Operating Income (Reported) | -$3.1M | -$44.1M | -$46.5M | -$41.5M | -$18.5M | |
| Operating Income (Adjusted) | -$3.1M | -$44.1M | -$46.5M | -$41.5M | -$18.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5M | $1.3M | $977K | $2.7M | $132K | |
| Revenue Growth (YoY) | -- | -15.65% | -22.21% | 180.25% | -95.18% | |
| Cost of Revenues | $347K | $1.5M | $1.5M | $477K | $312K | |
| Gross Profit | $1.1M | -$261K | -$507K | $2.3M | -$180K | |
| Gross Profit Margin | 76.7% | -20.78% | -51.89% | 82.58% | -136.36% | |
| R&D Expenses | $29K | $2.1M | $3.1M | $1.4M | $356K | |
| Selling, General & Admin | $7.9M | $10.5M | $8.5M | $6.2M | $2.3M | |
| Other Inc / (Exp) | $9.9M | $8.4M | $522K | -$4.7M | -$91K | |
| Operating Expenses | $8.1M | $12.8M | $11.3M | $6.8M | $2.8M | |
| Operating Income | -$7M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Net Interest Expenses | $10K | $10K | -- | $232K | $244K | |
| EBT. Incl. Unusual Items | $2.9M | -$4.8M | -$11.2M | -$9.5M | -$3.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $60K | -- | |
| Income Tax Expense | -- | -$657K | $796K | -$55K | $1K | |
| Net Income to Company | -- | -- | -$12M | -$9.4M | -$3.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.9M | -$4.1M | -$12M | -$9.4M | -$3.3M | |
| Basic EPS (Cont. Ops) | $2.40 | -$2.40 | -$6.93 | -$3.62 | -$1.24 | |
| Diluted EPS (Cont. Ops) | $2.10 | -$2.40 | -$6.93 | -$3.62 | -$1.24 | |
| Weighted Average Basic Share | $1.3M | $1.7M | $1.7M | $2.6M | $2.6M | |
| Weighted Average Diluted Share | $1.4M | $1.7M | $1.7M | $2.6M | $2.6M | |
| EBITDA | $3.1M | -$12.4M | -$11.2M | -$3.8M | -$2.7M | |
| EBIT | $2.9M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Revenue (Reported) | $1.5M | $1.3M | $977K | $2.7M | $132K | |
| Operating Income (Reported) | -$7M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Operating Income (Adjusted) | $2.9M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3M | $6.8M | $7.6M | $5.3M | $821K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $794.8K | $6.6M | $8.5M | $8.8M | $1.4M | |
| Gross Profit | $1.5M | $260K | -$990K | -$3.5M | -$574K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $87.9K | $5.7M | $10.8M | $8.3M | $5.1M | |
| Selling, General & Admin | $11.2M | $44.5M | $33.9M | $40.6M | $19.1M | |
| Other Inc / (Exp) | $10M | $21.2M | -$37.7M | -$15M | $3.9M | |
| Operating Expenses | $11.3M | $50.5M | $44.2M | $47.3M | $27.7M | |
| Operating Income | -$9.8M | -$50.3M | -$45.2M | -$50.9M | -$28.2M | |
| Net Interest Expenses | $13K | $51K | -- | -- | $547K | |
| EBT. Incl. Unusual Items | $142.1K | -$29.1M | -$82.7M | -$65.5M | -$24.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$3.3M | -$10M | |
| Income Tax Expense | -- | -$1.6M | -$517K | -$10K | $1K | |
| Net Income to Company | -- | -- | -- | -$48.3M | -$23.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $142.1K | -$27.5M | -$82.2M | -$68.8M | -$34.9M | |
| Basic EPS (Cont. Ops) | -$1.50 | -$16.80 | -$47.73 | -$34.23 | -$13.25 | |
| Diluted EPS (Cont. Ops) | -$1.80 | -$16.80 | -$47.73 | -$34.23 | -$13.25 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $383.8K | -$48.5M | -$42.5M | -$48.3M | -$27.1M | |
| EBIT | $196.8K | -$50.3M | -$45.2M | -$50.9M | -$28.2M | |
| Revenue (Reported) | $2.3M | $6.8M | $7.6M | $5.3M | $821K | |
| Operating Income (Reported) | -$9.8M | -$50.3M | -$45.2M | -$50.9M | -$28.2M | |
| Operating Income (Adjusted) | $196.8K | -$50.3M | -$45.2M | -$50.9M | -$28.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5M | $1.3M | $977K | $2.7M | $132K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $347K | $1.5M | $1.5M | $477K | $312K | |
| Gross Profit | $1.1M | -$261K | -$507K | $2.3M | -$180K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $29K | $2.1M | $3.1M | $1.4M | $356K | |
| Selling, General & Admin | $7.9M | $10.5M | $8.5M | $6.2M | $2.3M | |
| Other Inc / (Exp) | $9.9M | $8.4M | $522K | -$4.7M | -$91K | |
| Operating Expenses | $8.1M | $12.8M | $11.3M | $6.8M | $2.8M | |
| Operating Income | -$7M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Net Interest Expenses | $10K | $10K | -- | $232K | $244K | |
| EBT. Incl. Unusual Items | $2.9M | -$4.8M | -$11.2M | -$9.5M | -$3.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $60K | -- | |
| Income Tax Expense | -- | -$657K | $796K | -$55K | $1K | |
| Net Income to Company | -- | -- | -$12M | -$9.4M | -$3.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.9M | -$4.1M | -$12M | -$9.4M | -$3.3M | |
| Basic EPS (Cont. Ops) | $2.40 | -$2.40 | -$6.93 | -$3.62 | -$1.24 | |
| Diluted EPS (Cont. Ops) | $2.10 | -$2.40 | -$6.93 | -$3.62 | -$1.24 | |
| Weighted Average Basic Share | $1.3M | $1.7M | $1.7M | $2.6M | $2.6M | |
| Weighted Average Diluted Share | $1.4M | $1.7M | $1.7M | $2.6M | $2.6M | |
| EBITDA | $3.1M | -$12.4M | -$11.2M | -$3.8M | -$2.7M | |
| EBIT | $2.9M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Revenue (Reported) | $1.5M | $1.3M | $977K | $2.7M | $132K | |
| Operating Income (Reported) | -$7M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Operating Income (Adjusted) | $2.9M | -$13.1M | -$11.8M | -$4.5M | -$2.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $515.7K | $79.8M | $32.9M | $3.2M | $381K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $421.1K | $3.1M | $979K | $63K | $962K | |
| Inventory | $107.9K | $7M | $12.6M | $195K | $8K | |
| Prepaid Expenses | $1.7K | $1.1M | $688K | $218K | $397K | |
| Other Current Assets | $24.5K | $298K | $121K | $1K | -- | |
| Total Current Assets | $1.7M | $97.4M | $49.5M | $8.8M | $2.7M | |
| Property Plant And Equipment | $198.7K | $8.6M | $22M | $24M | $5M | |
| Long-Term Investments | -- | -- | $320K | -- | -- | |
| Goodwill | -- | $30M | $5.7M | -- | -- | |
| Other Intangibles | -- | $23.3M | $6.1M | $79K | $85K | |
| Other Long-Term Assets | $140 | $2.5M | $6M | $1.6M | $17K | |
| Total Assets | $1.9M | $163M | $89.6M | $34.7M | $8M | |
| Accounts Payable | $881.4K | $4.8M | $4.7M | $4M | $16.7M | |
| Accrued Expenses | $815K | $5.9M | $1.5M | $653K | $388K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $2.3M | $2.1M | $89K | |
| Other Current Liabilities | -- | -- | -- | $3.6M | $5.1M | |
| Total Current Liabilities | $3.4M | $18.9M | $13.7M | $11.9M | $28.8M | |
| Long-Term Debt | $42.8K | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.7M | $32.8M | $25.4M | $21.3M | $29.3M | |
| Common Stock | $2.5K | $5K | $5K | $8K | -- | |
| Other Common Equity Adj | $111.8K | -$1.3M | -$2.6M | -$2.3M | -$157K | |
| Common Equity | -$1.8M | $130.2M | $64.1M | $13.4M | -$21.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.8M | $130.2M | $64.1M | $13.4M | -$21.3M | |
| Total Liabilities and Equity | $1.9M | $163M | $89.6M | $34.7M | $8M | |
| Cash and Short Terms | $515.7K | $79.8M | $32.9M | $3.2M | $381K | |
| Total Debt | $42.8K | -- | -- | -- | $559K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $125M | $59.3M | $19.5M | $774K | $329K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.1M | $2.8M | $563K | $1.1M | $141K | |
| Inventory | $812.7K | $9.2M | $14.9M | $2.1M | -- | |
| Prepaid Expenses | $2.9M | -- | $1.7M | $2.1M | $522K | |
| Other Current Assets | $891.2K | $10.2M | $45K | $9K | -- | |
| Total Current Assets | $131.8M | $82.6M | $39M | $7.2M | $2M | |
| Property Plant And Equipment | $318K | $9M | $24.2M | $23.8M | $4.9M | |
| Long-Term Investments | -- | -- | $326K | -- | -- | |
| Goodwill | -- | $30M | $5.7M | -- | -- | |
| Other Intangibles | -- | $22.7M | $5.8M | $77K | $104K | |
| Other Long-Term Assets | -- | $2.5M | $5.8M | $1.1M | $17K | |
| Total Assets | $137.3M | $148.2M | $80.9M | $32.2M | $7.2M | |
| Accounts Payable | $1.5M | $5.5M | $5.4M | $5.7M | $17.9M | |
| Accrued Expenses | $956.1K | $1.7M | $1.6M | $813K | $432K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $2.4M | $2.2M | $148K | |
| Other Current Liabilities | $2M | -- | -- | $5.1M | $5.4M | |
| Total Current Liabilities | $5M | $14.4M | $14.9M | $17.3M | $31.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $28.6M | $19.6M | $25.8M | $26.1M | $31.9M | |
| Common Stock | $4.6K | $5K | $5K | -- | -- | |
| Other Common Equity Adj | $130.7K | -$1.7M | -$2.3M | -$2.4M | -$663K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $108.7M | $128.5M | $55.1M | $6.1M | -$24.7M | |
| Total Liabilities and Equity | $137.3M | $148.2M | $80.9M | $32.2M | $7.2M | |
| Cash and Short Terms | $125M | $59.3M | $19.5M | $774K | $329K | |
| Total Debt | -- | -- | -- | -- | $345K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.1M | -$20.5M | -$74.3M | -$50.9M | -$30M | |
| Depreciation & Amoritzation | $22.5K | $1.7M | $4.3M | $2.5M | $1.6M | |
| Stock-Based Compensation | $869.5K | $7.7M | $10.4M | $9.9M | $3.8M | |
| Change in Accounts Receivable | -$206.4K | -$305K | $2.5M | $577K | $66K | |
| Change in Inventories | -$75.5K | -$1.6M | -$5.9M | $838K | $217K | |
| Cash From Operations | -$1.4M | -$35.8M | -$32.1M | -$21M | $1.4M | |
| Capital Expenditures | $122.5K | $6.1M | $14.2M | $3.7M | $83K | |
| Cash Acquisitions | -- | -$19.4M | -- | -$1.9M | -- | |
| Cash From Investing | -$122.5K | -$25.6M | -$14.5M | -$5.3M | $1.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $118K | -- | -- | $660K | |
| Long-Term Debt Repaid | -$500K | -- | -$40K | -- | -$101K | |
| Repurchase of Common Stock | -$69.4K | -- | -- | -- | -- | |
| Other Financing Activities | -- | $141.1M | -- | -- | -- | |
| Cash From Financing | $882.3K | $141.5M | -$40K | $9.1M | $850K | |
| Beginning Cash (CF) | $1.2M | $516K | $79.8M | $33.6M | $4.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$665.3K | $80.1M | -$46.7M | -$29.3M | -$4M | |
| Ending Cash (CF) | $515.7K | $79.8M | $33.6M | $4.4M | $381K | |
| Levered Free Cash Flow | -$1.5M | -$42M | -$46.3M | -$24.7M | $1.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$12M | -$9.4M | -$3.3M | |
| Depreciation & Amoritzation | -- | -- | $622K | $685K | $195K | |
| Stock-Based Compensation | -- | -- | $2.6M | $1.9M | $393K | |
| Change in Accounts Receivable | -- | -- | $222K | -$887K | $989K | |
| Change in Inventories | -- | -- | -$2M | -$161K | $7K | |
| Cash From Operations | -$12.2M | -$19.3M | -$11.4M | -$2.6M | $282K | |
| Capital Expenditures | $77K | $1M | $1.9M | $29K | $29K | |
| Cash Acquisitions | -$4M | -- | -- | -- | -- | |
| Cash From Investing | -$4.1M | -$1M | -$1.9M | -$29K | -$29K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$214K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $140.7M | -- | -- | -- | -- | |
| Cash From Financing | $140.7M | -- | -- | $126K | -$214K | |
| Beginning Cash (CF) | $516K | $79.8M | $33.6M | $4.4M | $381K | |
| Foreign Exchange Rate Adjustment | $15K | -$161K | $11K | -$11K | -$91K | |
| Additions / Reductions | $124.4M | -$20.3M | -$13.3M | -$2.8M | $39K | |
| Ending Cash (CF) | $125M | $59.3M | $20.3M | $1.6M | $329K | |
| Levered Free Cash Flow | -$12.3M | -$20.3M | -$13.3M | -$2.6M | $253K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$48.3M | -$23.9M | |
| Depreciation & Amoritzation | -- | -- | -- | $2.6M | $1.1M | |
| Stock-Based Compensation | -- | -- | $2.6M | $9.2M | $2.2M | |
| Change in Accounts Receivable | -- | -- | -- | -$532K | $1.9M | |
| Change in Inventories | -- | -- | -- | $2.7M | $385K | |
| Cash From Operations | -- | -$43M | -$24.3M | -$12.1M | $4.3M | |
| Capital Expenditures | $77K | $7.1M | $15.1M | $1.8M | $83K | |
| Cash Acquisitions | -$4M | -$15.4M | -- | -$1.9M | -- | |
| Cash From Investing | -- | -$22.5M | -$15.4M | -$3.5M | $1.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -$40K | $9.2M | $510K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$64.7M | -$39.7M | -$18.7M | -$1.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$50M | -$39.3M | -$14M | $4.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$12M | -$9.4M | -$3.3M | |
| Depreciation & Amoritzation | -- | -- | $622K | $685K | $195K | |
| Stock-Based Compensation | -- | -- | $2.6M | $1.9M | $393K | |
| Change in Accounts Receivable | -- | -- | $222K | -$887K | $989K | |
| Change in Inventories | -- | -- | -$2M | -$161K | $7K | |
| Cash From Operations | -$12.2M | -$19.3M | -$11.4M | -$2.6M | $282K | |
| Capital Expenditures | $77K | $1M | $1.9M | $29K | $29K | |
| Cash Acquisitions | -$4M | -- | -- | -- | -- | |
| Cash From Investing | -$4.1M | -$1M | -$1.9M | -$29K | -$29K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$214K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $140.7M | -- | -- | -- | -- | |
| Cash From Financing | $140.7M | -- | -- | $126K | -$214K | |
| Beginning Cash (CF) | $516K | $79.8M | $33.6M | $4.4M | $381K | |
| Foreign Exchange Rate Adjustment | $15K | -$161K | $11K | -$11K | -$91K | |
| Additions / Reductions | $124.4M | -$20.3M | -$13.3M | -$2.8M | $39K | |
| Ending Cash (CF) | $125M | $59.3M | $20.3M | $1.6M | $329K | |
| Levered Free Cash Flow | -$12.3M | -$20.3M | -$13.3M | -$2.6M | $253K | |
Get ADN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ADN
Sector
P/E ratio
--
18.58x
PEG ratio
0.00x
0.25x
P/B ratio
1.66x
1.75x
Price / LTM sales
6.25x
0.94x
Growth Metrics
ADN
Sector
Revenue growth
14.29%
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
--
4.35%
Earnings forecast
--
$0.40
Profitability
ADN
Sector
Profitability FY 2024
$1.8M
$393.9M
Return on invested capital
-1023.62%
5.32%
Return on assets
-225.31%
3.49%
Return on equity
-1041.26%
8.55%
Earnings Date
Last Earnings Date
Jun
30
Next Earnings Date
Oct
15
Estimated Next Earnings Date
Sep
29
Balance Sheet
ADN
Sector
Total cash
$192K
$154.3M
Short term investments
--
$35.5M
Total assets
$8M
$1.7B
Long term debt
--
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
